<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11275</article-id><article-id pub-id-type="doi">10.7554/eLife.11275</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Comparative analysis of viral RNA signatures on different RIG-I-like receptors</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-42479"><name><surname>Sanchez David</surname><given-names>Raul Y</given-names></name><aff><institution content-type="dept">Unité de Génomique Virale et Vaccination</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42480"><name><surname>Combredet</surname><given-names>Chantal</given-names></name><aff><institution content-type="dept">Unité de Génomique Virale et Vaccination</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42481"><name><surname>Sismeiro</surname><given-names>Odile</given-names></name><aff><institution content-type="dept">Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-32305"><name><surname>Dillies</surname><given-names>Marie-Agnès</given-names></name><aff><institution content-type="dept">Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42482"><name><surname>Jagla</surname><given-names>Bernd</given-names></name><aff><institution content-type="dept">Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42483"><name><surname>Coppée</surname><given-names>Jean-Yves</given-names></name><aff><institution content-type="dept">Transcriptome and Epigenome, BioMics Pole, Center for Innovation and Technological Research</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42484"><name><surname>Mura</surname><given-names>Marie</given-names></name><aff><institution content-type="dept">Unité de Génomique Virale et Vaccination</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42485"><name><surname>Guerbois Galla</surname><given-names>Mathilde</given-names></name><aff><institution>University of Texas Medical Branch</institution>, <addr-line><named-content content-type="city">Galveston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50544"><name><surname>Despres</surname><given-names>Philippe</given-names></name><aff><institution content-type="dept">Technology platform CYROI</institution>, <institution>University of Reunion Island</institution>, <addr-line><named-content content-type="city">Saint-Clotilde</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-42487"><name><surname>Tangy</surname><given-names>Frédéric</given-names></name><aff><institution content-type="dept">Unité de Génomique Virale et Vaccination</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-41094"><name><surname>Komarova</surname><given-names>Anastassia V</given-names></name><aff><institution content-type="dept">Unité de Génomique Virale et Vaccination</institution>, <institution>Institut Pasteur</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country><email>stasy@pasteur.fr</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-11686"><name><surname>Cao</surname><given-names>Xuetao</given-names></name><role>Reviewing editor</role><aff><institution>Zhejiang University School of Medicine</institution>, <country>China</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>24</day><month>03</month><year>2016</year></pub-date><elocation-id>e11275</elocation-id><supplementary-material><ext-link xlink:href="elife-11275-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>01</day><month>09</month><year>2015</year></date><date date-type="accepted"><day>24</day><month>03</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Sanchez David et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Sanchez David et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>The RIG-I-like receptors (RLRs) play a major role in sensing RNA virus infection to initiate and modulate antiviral immunity. They interact with particular viral RNAs, most of them being still unknown. To decipher the viral RNA signature on RLRs during viral infection, we tagged RLRs (RIG-I, MDA5, LGP2) and applied tagged protein affinity purification followed by next-generation sequencing (NGS) of associated RNA molecules. Two viruses with negative- and positive-sense RNA genome were used: measles (MV) and chikungunya (CHIKV). NGS analysis revealed that distinct regions of MV genome were specifically recognized by distinct RLRs: RIG-I recognized defective interfering genomes, whereas MDA5 and LGP2 specifically bound MV nucleoprotein-coding region. During CHIKV infection, RIG-I associated specifically to the 3' untranslated region of viral genome. This study provides the first comparative view of the viral RNA ligands for RIG-I, MDA5 and LGP2 in the presence of infection.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></back></article>